The chondrocytic journey in endochondral bone growth and skeletal dysplasia

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 102, Issue 1, 2014, Pages 52-73

  Yeung Tsang, Kwok ^a   Wa Tsang, Shun ^a   Chan, Danny ^a   Cheah, Kathryn S E ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chondrocyte differentiation; Endochondral ossification; Mesenchymal condensation; Skeletal dysplasia; Sox9

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; FIBROBLAST GROWTH FACTOR; HEPATOCYTE NUCLEAR FACTOR 3BETA; HYPOXIA INDUCIBLE FACTOR 1; PARATHYROID HORMONE RELATED PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

ACROCAPITOFEMORAL DYSPLASIA; ARTICLE; BONE DEVELOPMENT; BONE DYSPLASIA; BRACHYDACTYLY; CAMPOMELIC DYSPLASIA; CARTILAGE; CARTILAGE CELL; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL FATE; CELL HYPOXIA; CELL LINEAGE; CELL MATURATION; CELL POLARITY; CELL PROLIFERATION; CELL STRESS; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CHONDRODYSPLASIA; CHONDROGENESIS; CLEIDOCRANIAL DYSPLASIA; ENCHONDRAL OSSIFICATION; EPIGENETICS; EXTRACELLULAR MATRIX; GROWTH PLATE; HOX GENE; HUMAN; LETHALITY; MESENCHYMAL CONDENSATION; MESENCHYME CELL; METAPHYSIS; METAPHYSIS DYSOSTOSIS; MYHRE RUVALCABA SYNDROME; NONHUMAN; PERINATAL PERIOD; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN FOLDING; ROBINOW SYNDROME; SIGNAL TRANSDUCTION; SPONDYLOEPIPHYSEAL DYSPLASIA; SYNPOLYDACTYLY; TYPE II ACHONDROGENESIS HYPOCHONDROGENESIS; ANIMAL; BONE; CYTOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; BONE DISEASES, DEVELOPMENTAL; CHONDROCYTES; CHONDROGENESIS; HUMANS;

EID: 84896960713     PISSN: 1542975X     EISSN: 15429768     Source Type: Journal    
DOI: 10.1002/bdrc.21060     Document Type: Article

References (241)

1. Ahmed YA, Tatarczuch L, Pagel CN, et al. 2007. Physiological death of hypertrophic chondrocytes. Osteoarthritis Cartilage 15:575-586.
2. Akiyama H, Chaboissier MC, Martin JF, et al. 2002. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16:2813-2828.
3. Akazawa H, Komuro I, Sugitani Y, et al. 2000. Targeted disruption of the homeobox transcription factor Bapx1 results in lethal skeletal dysplasia with asplenia and gastroduodenal malformation. Genes Cells 5:499-513.
4. Akiyama H, Lyons JP, Mori-Akiyama Y, et al. 2004. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev 18:1072-1087.
5. Albrecht AN, Schwabe GC, Stricker S, et al. 2002. The synpolydactyly homolog (spdh) mutation in the mouse-a defect in patterning and growth of limb cartilage elements. Mech Dev 112:53-67.
6. Amano K, Hata K, Muramatsu S, et al. 2011. Arid5a cooperates with Sox9 to stimulate chondrocyte-specific transcription. Mol Biol Cell 22:1300-1311.
7. Amano K, Ichida F, Sugita A, et al. 2008. MSX2 stimulates chondrocyte maturation by controlling Ihh expression. J Biol Chem 283:29513-29521.
8. Amarilio R, Viukov SV, Sharir A, et al. 2007. HIF1alpha regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis. Development 134:3917-3928.
9. Amizuka N, Hasegawa T, Oda K, et al. 2012. Histology of epiphyseal cartilage calcification and endochondral ossification. Front in Biosci (Elite Ed) 4:2085-2100.
10. Araldi E, Khatri R, Giaccia AJ, et al. 2011. Lack of HIF-2 [alpha] in limb bud mesenchyme causes a modest and transient delay of endochondral bone development. Nat Med 17:25-26.
11. Arnold MA, Kim Y, Czubryt MP, et al. 2007. MEF2C transcription factor controls chondrocyte hypertrophy and bone development. Dev Cell 12:377-389.
12. Aro E, Khatri R, Gerard-O'Riley R, et al. 2012. Hypoxia-inducible factor-1 (HIF-1) but not HIF-2 is essential for hypoxic induction of collagen prolyl 4-hydroxylases in primary newborn mouse epiphyseal growth plate chondrocytes. J Biol Chem 287:37134-37144.
13. Aszodi A, Hunziker EB, Brakebusch C, Fassler R. 2003. Beta1 integrins regulate chondrocyte rotation, G1 progression, and cytokinesis. Genes Dev 17:2465-2479.
14. Bandyopadhyay A, Tsuji K, Cox K, et al. 2006. Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genet 2:e216.
15. Barbieri O, Astigiano S, Morini M, et al. 2003. Depletion of cartilage collagen fibrils in mice carrying a dominant negative Col2a1 transgene affects chondrocyte differentiation. Am J Physiol Cell Physiol 285:C1504-C1512.
16. Barna M, Niswander L. 2007. Visualization of cartilage formation: insight into cellular properties of skeletal progenitors and chondrodysplasia syndromes. Dev Cell 12:931-941.
17. Beier F. 2005. Cell-cycle control and the cartilage growth plate. J Cell Physiol 202:1-8.
18. Beier F, Ali Z, Mok D, et al. 2001. TGFbeta and PTHrP control chondrocyte proliferation by activating cyclin D1 expression. Mol Biol Cell 12:3852-3863.
19. Bell DM, Leung KK, Wheatley SC, et al. 1997. SOX9 directly regulates the type-II collagen gene. Nat Genet 16:174-178.
20. Benazet JD, Pignatti E, Nugent A, et al. 2012. Smad4 is required to induce digit ray primordia and to initiate the aggregation and differentiation of chondrogenic progenitors in mouse limb buds. Development 139:4250-4260.
21. Bernard P, Tang P, Liu S, et al. 2003. Dimerization of SOX9 is required for chondrogenesis, but not for sex determination. Hum Mol Genet 12:1755-1765.
22. Bi W, Deng JM, Zhang Z, et al. 1999. Sox9 is required for cartilage formation. Nat Genet 22:85-89.
23. Bi W, Huang W, Whitworth DJ, et al. 2001. Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci USA 98:6698-6703.
24. Bianco P, Cancedda FD, Riminucci M, Cancedda R. 1998. Bone formation via cartilage models: the "borderline" chondrocyte. Matrix Biol 17:185-192.
25. Brachet A. 1893. Etude sur la resorption du cartilage et le developpement des os longs chez les oiseaux. J Anat Physiol 10:391-417.
26. Bradley EW, Carpio LR, Westendorf JJ. 2013. Histone deacetylase 3 suppression increases PH domain and leucine-rich repeat phosphatase (Phlpp) 1 expression in chondrocytes to suppress Akt signaling and matrix secretion. J Biol Chem 288:9572-9582.
27. Brison N, Debeer P, Tylzanowski P. 2014. Joining the fingers: a HOXD13 story. Dev Dyn 243:37-48.
28. Cancedda FD, Gentili C, Manduca P, Cancedda R. 1992. Hypertrophic chondrocytes undergo further differentiation in culture. J Cell Biol 117:427-435.
29. Chan D, Cole WG, Chow CW, et al. 1995. A COL2A1 mutation in achondrogenesis type II results in the replacement of type II collagen by type I and III collagens in cartilage. J Biol Chem 270:1747-1753.
30. Chen L, Adar R, Yang X, et al. 1999. Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. J Clin Invest 104:1517-1525.
31. Chen D, Bashur LA, Liang B, et al. 2013. The transcriptional co-regulator Jab1 is crucial for chondrocyte differentiation in vivo. J Cell Sci 126:234-243.
32. Chen Y, Gridley T. 2013. Compensatory regulation of the Snai1 and Snai2 genes during chondrogenesis. J Bone Miner Res 28:1412-1421.
33. Chen M, Lichtler AC, Sheu T-J, et al. 2007. Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression of Cre recombinase. Genesis 45:44-50.
34. Choi SW, Jeong DU, Kim JA, et al. 2012. Indian Hedgehog signalling triggers Nkx3.2 protein degradation during chondrocyte maturation. Biochem J 443:789-798.
35. Clevers H. 2006. Wnt/β-catenin signaling in development and disease. Cell 127:469-480.
36. Cobrinik D, Lee MH, Hannon G, et al. 1996. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev 10:1633-1644.
37. Colvin JS, Bohne BA, Harding GW, et al. 1996. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat Genet 12:390-397.
38. Cong L, Ran FA, Cox D, et al. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339:819-823.
39. Cooper KL, Oh S, Sung Y, et al. 2013. Multiple phases of chondrocyte enlargement underlie differences in skeletal proportions. Nature 495:375-378.
40. Correa D, Hesse E, Seriwatanachai D, et al. 2010. Zfp521 is a target gene and key effector of parathyroid hormone-related peptide signaling in growth plate chondrocytes. Dev Cell 19:533-546.
41. Craft AM, Ahmed N, Rockel JS, et al. 2013. Specification of chondrocytes and cartilage tissues from embryonic stem cells. Development 140:2597-2610.
42. D'Alonzo RC, Selvamurugan N, Karsenty G, Partridge NC. 2002. Physical interaction of the activator protein-1 factors c-Fos and c-Jun with Cbfa1 for collagenase-3 promoter activation. J Biol Chem 277:816-822.
43. Dailey L, Laplantine E, Priore R, Basilico C. 2003. A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation. J Cell Biol 161:1053-1066.
44. Day TF, Guo X, Garrett-Beal L, Yang Y. 2005. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8:739-750.
45. de Frutos CA, Vega S, Manzanares M, et al. 2007. Snail1 is a transcriptional effector of FGFR3 signaling during chondrogenesis and achondroplasias. Dev Cell 13:872-883.
46. Deng C, Wynshaw-Boris A, Zhou F, et al. 1996. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84:911-921.
47. Ducy P, Zhang R, Geoffroy V, et al. 1997. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:747-754.
48. Dy P, Wang W, Bhattaram P, et al. 2012. Sox9 directs hypertrophic maturation and blocks osteoblast differentiation of growth plate chondrocytes. Dev Cell 22:597-609.
49. Enomoto H, Enomoto-Iwamoto M, Iwamoto M, et al. 2000. Cbfa1 is a positive regulatory factor in chondrocyte maturation. J Biol Chem 275:8695-8702.
50. Erenpreisa J, Roach HI. 1996. Epigenetic selection as a possible component of transdifferentiation. Further study of the commitment of hypertrophic chondrocytes to become osteocytes. Mech Ageing Dev 87:165-182.
51. Feinberg RN, Latker CH, Beebe DC. 1986. Localized vascular regression during limb morphogenesis in the chicken embryo. I. Spatial and temporal changes in the vascular pattern. Anat Rec 214:405-409.
52. Foster JW, Dominguez-Steglich MA, Guioli S, et al. 1994. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372:525-530.
53. Gao B, Song H, Bishop K, Elliot G, et al. 2011. Wnt signaling gradients establish planar cell polarity by inducing Vangl2 phosphorylation through Ror2. Dev Cell 20:163-176.
54. Garcia S, Dirat B, Tognacci T, et al. 2013. Postnatal soluble FGFR3 therapy rescues achondroplasia symptoms and restores bone growth in mice. Sci Transl Med 5:203ra124.
55. Gebhard S, Hattori T, Bauer E, et al. 2008. Specific expression of Cre recombinase in hypertrophic cartilage under the control of a BAC-Col10a1 promoter. Matrix Biol 27:693-699.
56. Gentili C, Bianco P, Neri M, et al. 1993. Cell proliferation, extracellular matrix mineralization, and ovotransferrin transient expression during in vitro differentiation of chick hypertrophic chondrocytes into osteoblast-like cells. J Cell Biol 122:703-712.
57. Gordon CT, Tan TY, Benko S, et al. 2009. Long-range regulation at the SOX9 locus in development and disease. J Med Genet 46:649-656.
58. Grandjean V, Smith J, Schofield PN, Ferguson-Smith AC. 2000. Increased IGF-II protein affects p57kip2 expression in vivo and in vitro: implications for Beckwith-Wiedemann syndrome. Proc Natl Acad Sci 97:5279-5284.
59. Gualeni B, Rajpar MH, Kellogg A, et al. 2013. A novel transgenic mouse model of growth plate dysplasia reveals that decreased chondrocyte proliferation due to chronic ER stress is a key factor in reduced bone growth. Dis Model Mech 6:1414-1425.
60. Haag J, Aigner T. 2006. Jun activation domain-binding protein 1 binds Smad5 and inhibits bone morphogenetic protein signaling. Arthritis Rheum 54:3878-3884.
61. Haberland M, Montgomery RL, Olson EN. 2009. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 10:32-42.
62. Hallmann R, Feinberg RN, Latker CH, et al. 1987. Regression of blood vessels precedes cartilage differentiation during chick limb development. Differentiation 34:98-105.
63. Hammond CL, Schulte-Merker S. 2009. Two populations of endochondral osteoblasts with differential sensitivity to Hedgehog signalling. Development 136:3991-4000.
64. Han Y, Lefebvre V. 2008. L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer. Mol Cell Biol 28:4999-5013.
65. Harada D, Yamanaka Y, Ueda K, et al. 2009. FGFR3-related dwarfism and cell signaling. J Bone Miner Metab 27:9-15.
66. Hattori T, Coustry F, Stephens S, et al. 2008. Transcriptional regulation of chondrogenesis by coactivator Tip60 via chromatin association with Sox9 and Sox5. Nucleic Acids Res 36:3011-3024.
67. Hattori T, Eberspaecher H, Lu J, et al. 2006. Interactions between PIAS proteins and SOX9 result in an increase in the cellular concentrations of SOX9. J Biol Chem 281:14417-14428.
68. Hattori T, Muller C, Gebhard S, et al. 2010. SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification. Development 137:901-911.
69. Hellemans J, Simon M, Dheedene A, et al. 2009. Homozygous inactivating mutations in the NKX3-2 gene result in spondylo-megaepiphyseal-metaphyseal dysplasia. Am J Hum Genet 85:916-922.
70. Hidvegi T, Ewing M, Hale P, et al. 2010. An autophagy-enhancing drug promotes degradation of mutant a1-antitrypsin Z and reduces hepatic fibrosis. Science 329:229-232.
71. Hill TP, Spater D, Taketo MM, et al. 2005. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 8:727-738.
72. Hilton MJ, Tu X, Long F. 2007. Tamoxifen-inducible gene deletion reveals a distinct cell type associated with trabecular bone, and direct regulation of PTHrP expression and chondrocyte morphology by Ihh in growth region cartilage. Dev Biol 308:93-105.
73. Ho MS, Tsang KY, Lo RL, et al. 2007. COL10A1 nonsense and frame-shift mutations have a gain-of-function effect on the growth plate in human and mouse metaphyseal chondrodysplasia type Schmid. Hum Mol Genet 16:1201-1215.
74. Hojo H, Ohba S, Taniguchi K, et al. 2013. Hedgehog-Gli activators direct osteo-chondrogenic function of bone morphogenetic protein toward osteogenesis in the perichondrium. J Biol Chem 288:9924-9932.
75. Hojo H, Ohba S, Yano F, et al. 2012. Gli1 protein participates in Hedgehog-mediated specification of osteoblast lineage during endochondral ossification. J Biol Chem 287:17860-17869.
76. Horton WA, Degnin CR. 2009. FGFs in endochondral skeletal development. Trends Endocrinol Metab 20:341-348.
77. Huang W, Chung UI, Kronenberg HM, de Crombrugghe B. 2001. The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. Proc Natl Acad Sci USA 98:160-165.
78. Huang W, Zhou X, Lefebvre V, de Crombrugghe B. 2000. Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase a enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer. Mol Cell Biol 20:4149-4158.
79. Hui CC, Angers S. 2011. Gli proteins in development and disease. Annu Rev Cell Dev Biol 27:513-537.
80. Hung IH, Yu K, Lavine KJ, Ornitz DM. 2007. FGF9 regulates early hypertrophic chondrocyte differentiation and skeletal vascularization in the developing stylopod. Dev Biol 307:300-313.
81. Ijiri K, Zerbini LF, Peng H, et al. 2005. A novel role for GADD45beta as a mediator of MMP-13 gene expression during chondrocyte terminal differentiation. J Biol Chem 280:38544-38555.
82. Ikegami D, Akiyama H, Suzuki A, et al. 2011. Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways. Development 138:1507-1519.
83. Inada M, Wang Y, Byrne MH, et al. 2004. Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc Natl Acad Sci USA 101:17192-17197.
84. Inada M, Yasui T, Nomura S, et al. 1999. Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn 214:279-290.
85. Inman CK, Shore P. 2003. The osteoblast transcription factor Runx2 is expressed in mammary epithelial cells and mediates osteopontin expression. J Biol Chem 278:48684-48689.
86. Ionescu A, Kozhemyakina E, Nicolae C, et al. 2012. FoxA family members are crucial regulators of the hypertrophic chondrocyte differentiation program. Dev Cell 22:927-939.
87. Iwai T, Murai J, Yoshikawa H, Tsumaki N. 2008. Smad7 Inhibits chondrocyte differentiation at multiple steps during endochondral bone formation and down-regulates p38 MAPK pathways. J Biol Chem 283:27154-27164.
88. Johansson N, Saarialho-Kere U, Airola K, et al. 1997. Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev Dyn 208:387-397.
89. Kahn AJ, Simmons DJ. 1977. Chondrocyte-to-osteocyte transformation in grafts of perichondrium-free epiphyseal cartilage. Clin Orthop Relat Res 129:299-304.
90. Karamboulas K, Dranse HJ, Underhill TM. 2010. Regulation of BMP-dependent chondrogenesis in early limb mesenchyme by TGFb signals. J Cell Sci 123:2068-2076.
91. Karsenty G, Kronenberg HM, Settembre C. 2009. Genetic control of bone formation. Annu Rev Cell Dev Biol 25:629-648.
92. Kearns AE, Khosla S, Kostenuik PJ. 2008. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev 29:155-192.
93. Keller B, Yang T, Chen Y, et al. 2011. Interaction of TGFbeta and BMP signaling pathways during chondrogenesis. PLoS One 6:e16421.
94. Kim IS, Otto F, Zabel B, Mundlos S. 1999. Regulation of chondrocyte differentiation by Cbfa1. Mech Dev 80:159-170.
95. Kim KO, Sampson ER, Maynard RD, et al. 2012. Ski inhibits TGF-beta/phospho-Smad3 signaling and accelerates hypertrophic differentiation in chondrocytes. J Cell Biochem 113:2156-2166.
96. King MA, Hands S, Hafiz F, et al. 2008. Rapamycin inhibits polyglutamine aggregation independently of autophagy by reducing protein synthesis. Mol Pharmacol 73:1052-1063.
97. Knauper V, Will H, Lopez-Otin C, et al. 1996. Cellular mechanisms for human procollagenase-3 (MMP-13) activation Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 271:17124-17131.
98. Knudson CB, Knudson W. 2001. Cartilage proteoglycans. Semin Cell Dev Biol 12:69-78.
99. Kobayashi T, Soegiarto DW, Yang Y, et al. 2005. Indian hedgehog stimulates periarticular chondrocyte differentiation to regulate growth plate length independently of PTHrP. J Clin Invest 115:1734-1742.
100. Kolupaeva V, Daempfling L, Basilico C. 2013. The B55alpha regulatory subunit of protein phosphatase 2A mediates fibroblast growth factor-induced p107 dephosphorylation and growth arrest in chondrocytes. Mol Cell Biol 33:2865-2878.
101. Komori T, Yagi H, Nomura S, et al. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
102. Koufos A, Grundy P, Morgan K, et al. 1989. Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. Am J Hum Genet 44:711-719.
103. Kozar K, Ciemerych MA, Rebel VI, et al. 2004. Mouse development and cell proliferation in the absence of D-cyclins. Cell 118:477-491.
104. Kozhemyakina E, Cohen T, Yao TP, Lassar AB. 2009. Parathyroid hormone-related peptide represses chondrocyte hypertrophy through a protein phosphatase 2A/histone deacetylase 4/MEF2 pathway. Mol Cell Biol 29:5751-5762.
105. Koziel L, Wuelling M, Schneider S, Vortkamp A. 2005. Gli3 acts as a repressor downstream of Ihh in regulating two distinct steps of chondrocyte differentiation. Development 132:5249-5260.
106. Kroemer G, Galluzzi L, Vandenabeele P, et al. 2009. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16:3-11.
107. Kundu M, Javed A, Jeon JP, et al. 2002. Cbfbeta interacts with Runx2 and has a critical role in bone development. Nat Genet 32:639-644.
108. Kuss P, Kraft K, Stumm J, et al. 2014. Regulation of cell polarity in the cartilage growth plate and perichondrium of metacarpal elements by HOXD13 and WNT5A. Dev Biol 385:83-93.
109. Kuss P, Villavicencio-Lorini P, Witte F, et al. 2009. Mutant Hoxd13 induces extra digits in a mouse model of synpolydactyly directly and by decreasing retinoic acid synthesis. J Clin Invest 119:146-156.
110. Lai LP, Lilley BN, Sanes JR, McMahon AP. 2013. Lkb1/Stk11 regulation of mTOR signaling controls the transition of chondrocyte fates and suppresses skeletal tumor formation. Proc Natl Acad Sci 110:19450-19455.
111. Landman AS, Danielian PS, Lees JA. 2013. Loss of pRB and p107 disrupts cartilage development and promotes enchondroma formation. Oncogene 32:4798-4805.
112. Lee SH, Che X, Jeong JH, et al. 2012. Runx2 protein stabilizes hypoxia-inducible factor-1alpha through competition with von Hippel-Lindau protein (pVHL) and stimulates angiogenesis in growth plate hypertrophic chondrocytes. J Biol Chem 287:14760-14771.
113. Lefebvre V, Huang W, Harley VR, et al. 1997. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17:2336-2346.
114. Lefebvre V, Smits P. 2005. Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res C Embryo Today 75:200-212.
115. Leighton MP, Nundlall S, Starborg T, et al. 2007. Decreased chondrocyte proliferation and dysregulated apoptosis in the cartilage growth plate are key features of a murine model of epiphyseal dysplasia caused by a matn3 mutation. Hum Mol Genet 16:1728-1741.
116. Lettice LA, Purdie LA, Carlson GJ, et al. 1999. The mouse bagpipe gene controls development of axial skeleton, skull, and spleen. Proc Natl Acad Sci USA 96:9695-9700.
117. Leung VY, Gao B, Leung KK, et al. 2011. SOX9 governs differentiation stage-specific gene expression in growth plate chondrocytes via direct concomitant transactivation and repression. PLoS Genet 7:e1002356.
118. Leung KK, Ng LJ, Ho KK, et al. 1998. Different cis-regulatory DNA elements mediate developmental stage- and tissue-specific expression of the human COL2A1 gene in transgenic mice. J Cell Biol 141:1291-1300.
119. Li Y, Ahrens MJ, Wu A, et al. 2011. Calcium/calmodulin-dependent protein kinase II activity regulates the proliferative potential of growth plate chondrocytes. Development 138:359-370.
120. Li C, Chen L, Iwata T, et al. 1999. A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors. Hum Mol Genet 8:35-44.
121. Li Y, Dudley AT. 2009. Noncanonical frizzled signaling regulates cell polarity of growth plate chondrocytes. Development 136:1083-1092.
122. Li Z, Gadue P, Chen K, et al. 2012. Foxa2 and H2A.Z mediate nucleosome depletion during embryonic stem cell differentiation. Cell 151:1608-1616.
123. Li SW, Prockop DJ, Helminen H, et al. 1995. Transgenic mice with targeted inactivation of the Col2 alpha 1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone. Genes Dev 9:2821-2830.
124. Liu JA, Wu MH, Yan CH, et al. 2013. Phosphorylation of Sox9 is required for neural crest delamination and is regulated downstream of BMP and canonical Wnt signaling. Proc Natl Acad Sci 110:2882-2887.
125. Liu Z, Xu J, Colvin JS, Ornitz DM. 2002. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev 16:859-869.
126. Liu Y, Zhou J, Zhao W, et al. 2012. XBP1S associates with RUNX2 and regulates chondrocyte hypertrophy. J Biol Chem 287:34500-34513.
127. Logan M, Martin JF, Nagy A, et al. 2002. Expression of Cre Recombinase in the developing mouse limb bud driven by a Prx1 enhancer. Genesis 33:77-80.
128. Long F, Zhang XM, Karp S, et al. 2001. Genetic manipulation of hedgehog signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation. Development 128:5099-5108.
129. MacLean HE, Guo J, Knight MC, et al. 2004. The cyclin-dependent kinase inhibitor p57(Kip2) mediates proliferative actions of PTHrP in chondrocytes. J Clin Invest 113:1334-1343.
130. Maes C, Kobayashi T, Selig MK, et al. 2010. Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev Cell 19:329-344.
131. Magne D, Bluteau G, Faucheux C, et al. 2003. Phosphate is a specific signal for ATDC5 chondrocyte maturation and apoptosis-associated mineralization: possible implication of apoptosis in the regulation of endochondral ossification. J Bone Miner Res 18:1430-1442.
132. Malumbres M, Barbacid M. 2009. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9:153-166.
133. Mansfield K, Pucci B, Adams CS, Shapiro IM. 2003. Induction of apoptosis in skeletal tissues: phosphate-mediated chick chondrocyte apoptosis is calcium dependent. Calcif Tissue Int 73:161-172.
134. Mansfield K, Rajpurohit R, Shapiro IM. 1999. Extracellular phosphate ions cause apoptosis of terminally differentiated epiphyseal chondrocytes. J Cell Physiol 179:276-286.
135. Martinez-Sanchez A, Dudek KA, Murphy CL. 2012. Regulation of human chondrocyte function through direct inhibition of cartilage master regulator SOX9 by microRNA-145 (miRNA-145). J Biol Chem 287:916-924.
136. Martinez-Sanchez A, Murphy CL. 2013. miR-1247 Functions by targeting cartilage transcription factor SOX9. J Biol Chem 288:30802-30814.
137. Massague J. 2004. G1 cell-cycle control and cancer. Nature 432:298-306.
138. Mau E, Whetstone H, Yu C, et al. 2007. PTHrP regulates growth plate chondrocyte differentiation and proliferation in a Gli3 dependent manner utilizing hedgehog ligand dependent and independent mechanisms. Dev Biol 305:28-39.
139. Maye P, Fu Y, Butler DL, et al. 2011. Generation and characterization of Col10a1-mcherry reporter mice. Genesis 49:410-418.
140. Mead TJ, Wang Q, Bhattaram P, et al. 2013. A far-upstream (-70 kb) enhancer mediates Sox9 auto-regulation in somatic tissues during development and adult regeneration. Nucleic Acids Res 41:4459-4469.
141. Miao D, Liu H, Plut P, et al. 2004. Impaired endochondral bone development and osteopenia in Gli2-deficient mice. Exp Cell Res 294:210-222.
142. Minina E, Kreschel C, Naski MC, et al. 2002. Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. Dev Cell 3:439-449.
143. Mitchell PG, Magna HA, Reeves LM, et al. 1996. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 97:761-768.
144. Miyaki S, Sato T, Inoue A, et al. 2010. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev 24:1173-1185.
145. Mo R, Freer AM, Zinyk DL, et al. 1997. Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development. Development 124:113-123.
146. Moskalewski S, Malejczyk J. 1989. Bone formation following intrarenal transplantation of isolated murine chondrocytes: chondrocyte-bone cell transdifferentiation? Development 107:473-480.
147. Muragaki Y, Mundlos S, Upton J, Olsen BR. 1996. Altered growth and branching patterns in synpolydactyly caused by mutations in HOXD13. Science 272:548-551.
148. Murakami S, Balmes G, McKinney S, et al. 2004. Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype. Genes Dev 18:290-305.
149. Nakamura Y, Inloes JB, Katagiri T, Kobayashi T. 2011. Chondrocyte-specific microRNA-140 regulates endochondral bone development and targets Dnpep to modulate bone morphogenetic protein signaling. Mol Cell Biol 31:3019-3028.
150. Nakamura E, Nguyen M-T, Mackem S. 2006. Kinetics of tamoxifen-regulated Cre activity in mice using a cartilage-specific CreERT to assay temporal activity windows along the proximodistal limb skeleton. Dev Dyn 235:2603-2612.
151. Ng LJ, Wheatley S, Muscat GE, et al. 1997. SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev Biol 183:108-121.
152. Nishimura R, Wakabayashi M, Hata K, et al. 2012. Osterix regulates calcification and degradation of chondrogenic matrices through matrix metalloproteinase 13 (MMP13) expression in association with transcription factor Runx2 during endochondral ossification. J Biol Chem 287:33179-33190.
153. Nishioka K, Itoh S, Suemoto H, et al. 2008. Trps1 deficiency enlarges the proliferative zone of growth plate cartilage by upregulation of Pthrp. Bone 43:64-71.
154. O'Brien CA. 2010. Control of RANKL gene expression. Bone 46:911-919.
155. Oh HJ, Kido T, Lau Y-FC. 2007. PIAS1 interacts with and represses SOX9 transactivation activity. Mol Reprod Dev 74:1446-1455.
156. Oh JH, Park SY, de CB, Kim JE. 2012. Chondrocyte-specific ablation of Osterix leads to impaired endochondral ossification. Biochem Biophys Res Commun 418:634-640.
157. Ohbayashi N, Shibayama M, Kurotaki Y, et al. 2002. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev 16:870-879.
158. Ornitz DM, Marie PJ. 2002. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 16:1446-1465.
159. Oshima Y, Akiyama T, Hikita A, et al. 2008. Pivotal role of Bcl-2 family proteins in the regulation of chondrocyte apoptosis. J Biol Chem 283:26499-26508.
160. Otto F, Thornell AP, Crompton T, et al. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771.
161. Ovchinnikov DA, Deng JM, Ogunrinu G, Behringer RR. 2000. Col2a1-directed expression of Cre recombinase in differentiating chondrocytes in transgenic mice. Genesis 26:145-146.
162. Ozcan L, Tabas I. 2012. Role of endoplasmic reticulum stress in metabolic disease and other disorders. Annu Rev Med 63:317-328.
163. Pan Q, Wu Y, Lin T, et al. 2009. Bone morphogenetic protein-2 induces chromatin remodeling and modification at the proximal promoter of Sox9 gene. Biochem Biophys Res Commun 379:356-361.
164. Pan Q, Yu Y, Chen Q, Li C, et al. 2008. Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter. J Cell Physiol 217:228-241.
165. Papaioannou G, Inloes JB, Nakamura Y, et al. 2013. let-7 and miR-140 microRNAs coordinately regulate skeletal development. Proc Natl Acad Sci USA 110:E3291-E3300.
166. Park HL, Bai C, Platt KA, et al. 2000. Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation. Development 127:1593-1605.
167. Peacock JD, Huk DJ, Ediriweera HN, Lincoln J. 2011. Sox9 transcriptionally represses spp1 to prevent matrix mineralization in maturing heart valves and chondrocytes. PLoS One 6:e26769.
168. Pereira ER, Frudd K, Awad W, Hendershot LM. 2014. Endoplasmic Reticulum (ER) Stress and Hypoxia Response Pathways Interact to Potentiate Hypoxia-inducible Factor 1 (HIF-1) Transcriptional Activity on Targets Like Vascular Endothelial Growth Factor (VEGF). J Biol Chem 289:3352-3364.
169. Pfander D, Kobayashi T, Knight MC, et al. 2004. Deletion of Vhlh in chondrocytes reduces cell proliferation and increases matrix deposition during growth plate development. Development 131:2497-2508.
170. Ping AJ, Reeve AE, Law DJ, et al. 1989. Genetic Linkage of Beckwith-Wiedemann syndrome to 11p15. Am J Hum Genet. 44:720-723.
171. Pirog-Garcia KA, Meadows RS, Knowles L, et al. 2007. Reduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain of COMP. Hum Mol Genet 16:2072-2088.
172. Potthoff MJ, Olson EN. 2007. MEF2: a central regulator of diverse developmental programs. Development 134:4131-4140.
173. Provot S, Kempf H, Murtaugh LC, et al. 2006. Nkx3.2/Bapx1 acts as a negative regulator of chondrocyte maturation. Development 133:651-662.
174. Rajpar MH, McDermott B, Kung L, et al. 2009. Targeted induction of endoplasmic reticulum stress induces cartilage pathology. PLoS Genet 5:e1000691.
175. Retting KN, Song B, Yoon BS, Lyons KM. 2009. BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation. Development 136:1093-1104.
176. Roach HI. 1997. New aspects of endochondral ossification in the chick: chondrocyte apoptosis, bone formation by former chondrocytes, and acid phosphatase activity in the endochondral bone matrix. J Bone Miner Res 12:795-805.
177. Roach HI, Aigner T, Kouri JB. 2004. Chondroptosis: a variant of apoptotic cell death in chondrocytes? Apoptosis 9:265-277.
178. Roach HI, Clarke NM. 1999. "Cell paralysis" as an intermediate stage in the programmed cell death of epiphyseal chondrocytes during development. J Bone Miner Res 14:1367-1378.
179. Roach HI, Clarke NM. 2000. Physiological cell death of chondrocytes in vivo is not confined to apoptosis. New observations on the mammalian growth plate. J Bone Joint Surg Br 82:601-613.
180. Roach HI, Erenpreisa J, Aigner T. 1995. Osteogenic differentiation of hypertrophic chondrocytes involves asymmetric cell divisions and apoptosis. J Cell Biol 131:483-494.
181. Rossi F, MacLean HE, Yuan W, et al. 2002. p107 and p130 Coordinately regulate proliferation, Cbfa1 expression, and hypertrophic differentiation during endochondral bone development. Dev Biol 247:271-285.
182. Rousseau F, El Ghouzzi V, Delezoide AL, et al. 1996. Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1). Hum Mol Genet 5:509-512.
183. Saito T, Fukai A, Mabuchi A, et al. 2010. Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development. Nat Med 16:678-686.
184. Saito A, Hino SI, Murakami T, et al. 2009. Regulation of endoplasmic reticulum stress response by a BBF2H7-mediated Sec23a pathway is essential for chondrogenesis. Nat Cell Biol 11:1197-1204.
185. Saito A, Kanemoto S, Zhang Y, et al. 2013. Chondrocyte proliferation regulated by secreted luminal domain of ER stress transducer BBF2H7/CREB3L2. Mol Cell 53:127-139.
186. Sakai K, Hiripi L, Glumoff V, et al. 2001. Stage-and tissue-specific expression of a Col2a1-Cre fusion gene in transgenic mice. Matrix Biol 19:761-767.
187. Sasagawa S, Takemori H, Uebi T, et al. 2012. SIK3 is essential for chondrocyte hypertrophy during skeletal development in mice. Development 139:1153-1163.
188. Sato M, Morii E, Komori T, et al. 1998. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues. Oncogene 17:1517-1525.
189. Schipani E, Ryan HE, Didrickson S, et al. 2001. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev 15:2865-2876.
190. Sekido R, Lovell-Badge R. 2008. Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature 453:930-934.
191. Serra R, Johnson M, Filvaroff EH, LaBorde J, et al. 1997. Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol 139:541-552.
192. Shapiro IM, Adams CS, Freeman T, Srinivas V. 2005. Fate of the hypertrophic chondrocyte: microenvironmental perspectives on apoptosis and survival in the epiphyseal growth plate. Birth Defects Res C Embryo Today 75:330-339.
193. Shu B, Zhang M, Xie R, et al. 2011. BMP2, but not BMP4, is crucial for chondrocyte proliferation and maturation during endochondral bone development. J Cell Sci 124:3428-3440.
194. Shung CY, Ota S, Zhou ZQ, et al. 2012. Disruption of a Sox9-β-catenin circuit by mutant Fgfr3 in thanatophoric dysplasia type II. Hum Mol Genet 21:4628-4644.
195. Smits P, Li P, Mandel J, et al. 2001. The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell 1:277-290.
196. Sock E, Pagon RA, Keymolen K, et al. 2003. Loss of DNA-dependent dimerization of the transcription factor SOX9 as a cause for campomelic dysplasia. Hum Mol Genet 12:1439-1447.
197. Stickens D, Behonick DJ, Ortega N, et al. 2004. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 131:5883-5895.
198. Su WC, Kitagawa M, Xue N, et al. 1997. Activation of Statl by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 386:288-292.
199. Tahirov TH, Inoue-Bungo T, Sasaki M, et al. 2001. Crystallization and preliminary X-ray analyses of quaternary, ternary and binary protein-DNA complexes with involvement of AML1/Runx-1/CBF Runt domain, CBF and the C/EBP bZip region. Acta Crystallogr D Biol Crystallogr 57:850-853.
200. Takarada T, Hinoi E, Nakazato R, et al. 2013. An analysis of skeletal development in osteoblast- and chondrocyte-specific Runx2 knockout mice. J Bone Miner Res 28:2064-2069.
201. Takigawa Y, Hata K, Muramatsu S, et al. 2010. The transcription factor Znf219 regulates chondrocyte differentiation by assembling a transcription factory with Sox9. J Cell Sci 123:3780-3788.
202. Topol L, Chen W, Song H, et al. 2009. Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus. J Biol Chem 284:3323-3333.
203. Tribioli C, Lufkin T. 1999. The murine Bapx1 homeobox gene plays a critical role in embryonic development of the axial skeleton and spleen. Development 126:5699-5711.
204. Tsang KY, Chan D, Bateman JF, Cheah KS. 2010. In vivo cellular adaptation to ER stress: survival strategies with double-edged consequences. J Cell Sci 123:2145-2154.
205. Tsang KY, Chan D, Cheslett D, et al. 2007. Surviving endoplasmic reticulum stress is coupled to altered chondrocyte differentiation and function. PLoS Biol 5:e44.
206. van der Stricht O. 1890. Recherches sur le cartilage articulaire des oiseaux. Arch Biol 10:1-41.
207. Vega RB, Matsuda K, Oh J, et al. 2004. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119:555-566.
208. Verdin E, Dequiedt F, Kasler HG. 2003. Class II histone deacetylases: versatile regulators. Trends Genet 19:286-293.
209. Villavicencio-Lorini P, Kuss P, Friedrich J, et al. 2010. Homeobox genes d11-d13 and a13 control mouse autopod cortical bone and joint formation. J Clin Invest 120:1994-2004.
210. Vortkamp A, Lee K, Lanske B, et al. 1996. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273:613-622.
211. Wagner T, Wirth J, Meyer J, et al. 1994. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79:1111-1120.
212. Wai AW, Ng LJ, Watanabe H, et al. 1998. Disrupted expression of matrix genes in the growth plate of the mouse cartilage matrix deficiency (cmd) mutant. Dev Genet 22:349-358.
213. Wang W, Lian N, Ma Y, et al. 2012. Chondrocytic Atf4 regulates osteoblast differentiation and function via Ihh. Development 139:601-611.
214. Warman ML, Cormier-Daire V, Hall C, et al. 2011. Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet A 155:943-968.
215. Watanabe H, Kimata K, Line S, et al. 1994. Mouse cartilage matrix deficiency (cmd) caused by a 7 bp deletion in the aggrecan gene. Nat Genet 7:154-157.
216. Watanabe H, Yamada Y. 2002. Chondrodysplasia of gene knockout mice for aggrecan and link protein. Glycoconj J 19:269-273.
217. Wilsman NJ, Farnum CE, Green EM, et al. 1996a. Cell cycle analysis of proliferative zone chondrocytes in growth plates elongating at different rates. J Orthop Res 14:562-572.
218. Wilsman NJ, Farnum CE, Leiferman EM, et al. 1996b. Differential growth by growth plates as a function of multiple parameters of chondrocytic kinetics. J Orthop Res 14:927-936.
219. Wuelling M, Kaiser FJ, Buelens LA, et al. 2009. Trps1, a regulator of chondrocyte proliferation and differentiation, interacts with the activator form of Gli3. Dev Biol 328:40-53.
220. Xiong J, Onal M, Jilka RL, et al. 2011. Matrix-embedded cells control osteoclast formation. Nat Med 17:1235-1241.
221. Yamashita S, Andoh M, Ueno-Kudoh H, et al. 2009. Sox9 directly promotes Bapx1 gene expression to repress Runx2 in chondrocytes. Exp Cell Res 315:2231-2240.
222. Yamashita S, Miyaki S, Kato Y, et al. 2012. L-Sox5 and Sox6 proteins enhance chondrogenic miR-140 microRNA expression by strengthening dimeric Sox9 activity. J Biol Chem 287:22206-22215.
223. Yan Y, Frisen J, Lee MH, et al. 1997. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev 11:973-983.
224. Yang G, Cui F, Hou N, et al. 2005. Transgenic mice that express Cre recombinasein hypertrophic chondrocytes. Genesis 42:33-36.
225. Yang H, Wang H, Shivalila CS, et al. 2013a. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 154:1370-1379.
226. Yang L, Lawson KA, Teteak CJ, et al. 2013b. ESET histone methyltransferase is essential to hypertrophic differentiation of growth plate chondrocytes and formation of epiphyseal plates. Dev Biol 380:99-110.
227. Yang S, Kim J, Ryu JH, et al. 2010. Hypoxia-inducible factor-2 [alpha] is a catabolic regulator of osteoarthritic cartilage destruction. Nat Med 16:687-693.
228. Yang Y, Topol L, Lee H, Wu J. 2003. Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation. Development 130:1003-1015.
229. Yasoda A, Komatsu Y, Chusho H, et al. 2004. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat Med 10:80-86.
230. Yoon BS, Lyons KM. 2004. Multiple functions of BMPs in chondrogenesis. J Cell Biochem 93:93-103.
231. Yoshida CA, Furuichi T, Fujita T, et al. 2002. Core-binding factor beta interacts with Runx2 and is required for skeletal development. Nat Genet 32:633-638.
232. Yoshida CA, Yamamoto H, Fujita T, et al. 2004. Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev 18:952-963.
233. Zakany J, Duboule D. 2007. The role of Hox genes during vertebrate limb development. Curr Opin Genet Dev 17:359-366.
234. Zelzer E, Glotzer DJ, Hartmann C, et al. 2001. Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev 106:97-106.
235. Zeng L, Kempf H, Murtaugh LC, et al. 2002. Shh establishes an Nkx3.2/Sox9 autoregulatory loop that is maintained by BMP signals to induce somitic chondrogenesis. Genes Dev 16:1990-2005.
236. Zhang P, Liegeois NJ, Wong C, et al. 1997. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387:151-158.
237. Zhang J, Tan X, Li W, et al. 2005. Smad4 is required for the normal organization of the cartilage growth plate. Dev Biol 284:311-322.
238. Zheng Q, Zhou G, Morello R, et al. 2003. Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J Cell Biol 162:833-842.
239. Zhou R, Bonneaud N, Yuan CX, et al. 2002. SOX9 interacts with a component of the human thyroid hormone receptor-associated protein complex. Nucleic Acids Res 30:3245-3252.
240. Zhou G, Zheng Q, Engin F, et al. 2006. Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc Natl Acad Sci USA 103:19004-19009.
241. Zhou X, Zhang Z, Feng JQ, et al. 2010. Multiple functions of Osterix are required for bone growth and homeostasis in postnatal mice. Proc Natl Acad Sci USA 107:12919-12924.